Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease-Reference-Cited by-同舟云学术

Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease

Published:2023-11-21 Issue:21 Volume:101 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Romanowska Julia¹^ORCID,Bjornevik Kjetil¹^ORCID,Cortese Marianna¹^ORCID,Tuominen Julia A.¹^ORCID,Solheim Magne¹^ORCID,Abolpour Mofrad Asieh¹^ORCID,Igland Jannicke¹^ORCID,Scherzer Clemens R.¹,Riise Trond¹^ORCID

Affiliation:

1. From the Department of Global Public Health and Primary Care (J.R., K.B., M.C., J.A.T., M.S., A.A.M., J.I., T.R.), University of Bergen, Norway; Department of Nutrition (K.B., M.C.), and Department of Epidemiology (K.B.), Harvard T.H. Chan School of Public Health; and Precision Neurology Program (C.R.S., T.R.), and APDA Center for Advanced Parkinson Research (C.R.S.), Harvard Medical School, Brigham and Women's Hospital, Boston, MA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207899

Reference50 articles.

1. The Emerging Evidence of the Parkinson Pandemic

2. Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

3. Innovation in the pharmaceutical industry: New estimates of R&D costs

4. Animal models of human disease: Challenges in enabling translation

5. Discovering New Benefits From Old Drugs With Big Data—Promise for Parkinson Disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morbus Parkinson: Risikomodifikation durch bestimmte Medikamentenklassen?;Neurologie up2date;2024-06

2. Renin-angiotensin system inhibitor use and risk of Parkinson’s disease: a meta-analysis;Acta Neurologica Belgica;2024-04-26